Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,848 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of high-dose epirubicin (EPI) plus cyclophosphamide (CPA) with G-CSF for breast cancer patients with visceral metastases or hormone-independent tumors: a trial of the Japan Clinical Oncology Group.
Takashima S, Saeki T, Adachi I, Watanabe T, Sasaki Y, Murai H, Tabei T, Ogita M, Sano M, Kanda K, Shimoyama M. Takashima S, et al. Jpn J Clin Oncol. 1997 Oct;27(5):325-30. doi: 10.1093/jjco/27.5.325. Jpn J Clin Oncol. 1997. PMID: 9390210 Clinical Trial.
Phase III trial of doxorubicin plus cyclophosphamide (AC), docetaxel, and alternating AC and docetaxel as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802).
Katsumata N, Watanabe T, Minami H, Aogi K, Tabei T, Sano M, Masuda N, Andoh J, Ikeda T, Shibata T, Takashima S. Katsumata N, et al. Among authors: takashima s. Ann Oncol. 2009 Jul;20(7):1210-5. doi: 10.1093/annonc/mdn781. Epub 2009 Mar 2. Ann Oncol. 2009. PMID: 19254942 Free article. Clinical Trial.
A phase I/II study of continuous intra-arterial chemotherapy using an implantable reservoir for the treatment of liver metastases from breast cancer: a Japan Clinical Oncology Group (JCOG) study 9113. JCOG Breast Cancer Study Group.
Ikeda T, Adachi I, Takashima S, Ogita M, Aoyama H, Sano M, Ando J, Tabei T, Tominaga T, Enomoto K, Kanda K, Fukutomi T, Shimoyama M. Ikeda T, et al. Among authors: takashima s. Jpn J Clin Oncol. 1999 Jan;29(1):23-7. doi: 10.1093/jjco/29.1.23. Jpn J Clin Oncol. 1999. PMID: 10073147 Clinical Trial.
Phase II study of paclitaxel (BMS-181339) intravenously infused over 3 hours for advanced or metastatic breast cancer in Japan. BMS-181339 Breast Cancer Study Group.
Ito Y, Horikoshi N, Watanabe T, Sasaki Y, Tominaga T, Okawa T, Tabei T, Kuraishi Y, Tamura K, Abe R, Kitajima M, Yamaguchi S, Kobayashi T, Koyama H, Orita K, Takashima S, Nomura Y, Ogawa M. Ito Y, et al. Among authors: takashima s. Invest New Drugs. 1998;16(2):183-90. doi: 10.1023/a:1006036923200. Invest New Drugs. 1998. PMID: 9848584 Clinical Trial.
1,848 results